Full Course:  20 AMA PRA Category 1 Credits for CME / CEU / CPD

Short Course:  10 AMA PRA Category 1 Credits for CME / CEU / CPD

Course(s) are appropriate for:   Urologists, Family Practitioners, Pediatricians, Internists, General Practitioners, Nurses, Nurse Practitioners, Physician Assistants (PA-C's)

Series 49 (URO49) Topics Include: 

To view topic outline of the full or short course, select the Course Type (Full or Short) below:

Full Course:
Full Course Price:
Short Course:
Short Course Price:
Available in Audio format.

Course Topics

Female Medicine from the 40th Annual Ralph E. Hopkins Urology Seminar

Assess methods for evaluating frailty among older adults; Diagnose and treat stress urinary incontinence using nonmesh alternatives; Select appropriate female candidates for treatment of urinary strictures via urethroplasty; Weigh advantages and disadvantages of the buccal mucosa graft technique for dorsal urethroplasty; Maximize patient satisfaction after surgical treatment of pelvic organ prolapse.

Urothelial Cell Carcinoma

Elaborate on molecular characteristics of muscle-invasive bladder cancer; Predict prognosis and response to treatment in a patient with muscle-invasive bladder cancer based on molecular characteristics and subtype; Weigh the oncologic and perioperative advantages and disadvantages of open radical cystectomy and robotassisted radical cystectomy; Assess the role of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer; Select patients with muscle-invasive bladder cancer most likely to benefit from adjuvant immunotherapy

Childhood Renal Tumors/Strictures After Hypospadias Repair/Partial Nephrectomy

Distinguish among renal tumors most often seen in children; Interpret genetic findings in children with renal tumors; Stage a renal tumor according to the guidelines from Children?s Oncology Group; Counsel patients who underwent hypospadias repair during childhood about the likelihood of recurrent urethral strictures; Choose surgical techniques that minimize risk for complications among patients undergoing partial nephrectomy.

Effects of Prostatectomy/Treatment of Penile Cancer/ Urinary Incontinence in Men

Ensure that patients have realistic expectations for sexual function and voiding after radical prostatectomy; Elaborate on the benefits of phosphodiesterase type 5 inhibitors for patients with ED after radical prostatectomy; Provide patients with effective options for the management of stress incontinence after radical prostatectomy; Optimize locoregional management of lymph nodes in patients with penile cancer; Select men with urinary incontinence after radical prostatectomy who are most likely to benefit from an artificial urinary sphincter.

Environmental Toxins /Penile Cancer

Identify common environmental toxins associated with male infertility; Review the effects of specific environmental toxins on the male reproductive system and risk for cancer; Predict prognosis of penile cancer based on staging, histology, and lymph node status; Develop strategies for prescribing nonsurgical therapy for penile cancer based on disease extent; Select the optimal surgical technique for management of penile cancer based on location and extent of disease and predicted prognosis.

Updates in Urogynecology

Optimize the use of urodynamic studies in women with stress urinary incontinence; Enhance surgical consultation and planning for women with stress urinary incontinence; Select women with stress urinary incontinence most likely to benefit from procedures using surgical mesh; Identify patients with asymptomatic bacteriuria who should not undergo antibiotic therapy before other options have been considered; Provide patients with effective options for prevention and treatment of urinary tract infection.

Latest AUA Guidelines /Kidney Cancer

Apply the 2019 American Urological Association (AUA) guidelines to the diagnosis and management of early-stage testicular cancer; Recommend appropriate diagnostic and therapeutic strategies for lower urinary tract symptoms caused by benign prostatic hyperplasia; Implement treatment for incontinence after prostate treatment based on 2019 guidelines from the American Urological Association; Choose appropriate strategies for the treatment of locally advanced kidney cancer; Assess clinical trial data on the efficacy and safety of adjuvant tyrosine kinase inhibitor therapy in the management of high-risk renal cell carcinoma.

Male Infertility/Prostate Cancer

Identify the etiology of male infertility; Select an effective therapeutic regimen for managing cases of severe male infertility; Summarize the role of neoadjuvant androgen deprivation therapy before prostatectomy; Evaluate and treat cancer recurrence after radiation therapy for localized prostate cancer; Counsel patients about the various treatment options for recurrent prostate cancer, including the life expectancy and morbidity associated with each.

Update on Urologic Stones and Surgery

Diagnose and locate calyceal diverticular stones; Compare the advantages and drawbacks of minimally and maximally invasive procedures for managing calyceal diverticular stones; Prevent, control, and definitively treat bleeding during minimally invasive renal surgery; Obtain percutaneous access to complex urologic stones; Summarize current and potential uses and benefits of robotics in transurethral surgery.

Refractory Urge Incontinence/Prostate Cancer/Chronic Prostatitis/Renal Masses

Select effective treatments for patients with refractory urge incontinence; Evaluate risks and benefits of treatment options for men and women with refractory overactive bladder; Identify patients most likely to benefit from genetic testing for mutations associated with prostate cancer; Distinguish among different types of chronic prostatitis; Choose a management strategy for a renal mass based on guidelines from the American Urological Association and patient selection criteria.


Additional Information

Additional Continuing Medical Education options available:

Other courses of interest may include:  PediatricsFamily PracticeInternal Medicine, DiabetesObesity and Nutrition.


  • Excellent diversity of speakers and subjects.

    William M., MD, Tennessee